|Articles|June 15, 2021
Analyzing SARS-CoV-2 Drugs Remdesivir and GS-441524
Author(s)YMC Europe GmbH
A fast separation of remdesivir and its active metabolite GS-441524 for the treatment of COVID-19 is obtained in only 3 minutes using a YMC-Triart C18 UHPLC column.
Newsletter
Join the global community of analytical scientists who trust LCGC for insights on the latest techniques, trends, and expert solutions in chromatography.
Trending on LCGC International
1
HPLC 2025 Revisited: A Year-End Review of LCGC's Conference Coverage Highlights (Part One)
2
A Novel Machine Learning Method for Predicting Retention Time of Small Molecule Pharmaceutical Compounds Across Reversed-phase HPLC Columns
3
Dr. Rigoberto Advincula on Advancing Polymer Research With Py-GC/MS
4
Best of the Week: Career Opportunities for PhD Graduates, Human Expertise and Machine Learning
5